Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 5:06 PM
Ignite Modification Date: 2025-12-25 @ 2:44 PM
NCT ID: NCT01494350
Description: None
Frequency Threshold: 2
Time Frame: 98 days
Study: NCT01494350
Study Brief: WR 279,396 Open Label Treatment Protocol in Tunisia
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
WR 279,396 Topical Cream WR 279,396 is a topical antibiotic cream containing paromomycin and gentamicin that will be applied to each lesion once a day for 20 days and covered with a sterile gauze and tape dressing. None None 0 50 39 50 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Application site vesicles NON_SYSTEMATIC_ASSESSMENT General disorders MedDRA (14.0) View
Oedema NON_SYSTEMATIC_ASSESSMENT General disorders MedDRA (14.0) View
Pain NON_SYSTEMATIC_ASSESSMENT General disorders MedDRA (14.0) View
Bronchitis acute NON_SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (14.0) View
Superinfection NON_SYSTEMATIC_ASSESSMENT General disorders MedDRA (14.0) View
Scratch NON_SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA (14.0) View
Thermal burn NON_SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA (14.0) View
Alanine aminotrasnsferase increased NON_SYSTEMATIC_ASSESSMENT Investigations MedDRA (14.0) View
Blood urea increased NON_SYSTEMATIC_ASSESSMENT Investigations MedDRA (14.0) View
Dermatitis contact NON_SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA (14.0) View
Skin irritation NON_SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA (14.0) View
Application site erythema NON_SYSTEMATIC_ASSESSMENT General disorders MedDRA (14.0) View